BRAVE Program for Early Psychosis
(BRAVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment As Usual (TAU)
Participants receive routine clinical care provided by early psychosis services
BRAVE Intervention
Participants receive the BRAVE intervention, a manualized CBT-based behavioral intervention, in addition to treatment as usual
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- BRAVE
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants will receive routine clinical care provided by early psychosis services.
Participants will receive BRAVE, a manualized CBT-based behavioral intervention, in addition to treatment as usual. BRAVE consists of weekly sessions delivered within early psychosis services and targets modifiable risk factors for violence.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Howard University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.